Results 201 to 210 of about 90,193 (247)

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial. [PDF]

open access: yesDermatol Ther (Heidelb)
Elbuluk N   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Home - About - Disclaimer - Privacy